Literature DB >> 11788929

Red blood cell hemolysis during processing.

Samuel O Sowemimo-Coker1.   

Abstract

Red blood cell (RBC) hemolysis has been reported in units of RBC for transfusion. This has significant clinical implications for transfused patients because the free hemoglobin dissociates into dimers that have to be bound to haptoglobin to be removed by the reticuloendothelial system. Once the binding capacity of haptoglobin has been exceeded, hemoglobinemia occurs. Hemolysis is caused by the breakdown of the RBC, causing release of hemoglobin and resulting in the discoloration of the plasma. Abnormal hemolysis in an individual RBC unit may be caused by several factors including inappropriate handling during processing of blood, inappropriate storage conditions, bacterial hemolysins, antibodies that cause complement lysis, defects in the RBC membrane, or an abnormality in the blood donor. The degree of hemolysis is described as the percent of free hemoglobin in relation to the total hemoglobin with appropriate correction for the hematocrit. The acceptable level of hemolysis has not been established in North America, but the value of 1% currently is used to assess biocompatibility of blood storage materials, whereas the Council of Europe has set the standard at 0.8%. This report emphasizes the need for the adequate control of the various processes that are involved in the preparation of RBCs from whole blood to minimize the occurrence of hemolysis. Careful evaluation of manufacturing processes will minimize RBC wastage caused by hemolysis. Copyright 2002 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2002        PMID: 11788929     DOI: 10.1053/tmrv.2002.29404

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  76 in total

1.  Maximizing peptide identification events in proteomic workflows using data-dependent acquisition (DDA).

Authors:  Nicholas W Bateman; Scott P Goulding; Nicholas J Shulman; Avinash K Gadok; Karen K Szumlinski; Michael J MacCoss; Christine C Wu
Journal:  Mol Cell Proteomics       Date:  2013-07-02       Impact factor: 5.911

2.  Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics.

Authors:  Kathleen A Stringer; John G Younger; Cora McHugh; Larisa Yeomans; Michael A Finkel; Michael A Puskarich; Alan E Jones; Julie Trexel; Alla Karnovsky
Journal:  Shock       Date:  2015-09       Impact factor: 3.454

3.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

4.  Detection of microparticles from human red blood cells by multiparametric flow cytometry.

Authors:  Giulia Grisendi; Elena Finetti; Daniele Manganaro; Nicoletta Cordova; Giuliano Montagnani; Carlotta Spano; Malvina Prapa; Valentina Guarneri; Satoru Otsuru; Edwin M Horwitz; Giorgio Mari; Massimo Dominici
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

5.  From Development to Implementation: Adjusting the Hematocrit of Deglycerolized Red Cell Concentrates to Meet Regulatory Standards.

Authors:  Tracey Turner; Adele Hansen; Jayme Kurach; Jason P Acker
Journal:  Transfus Med Hemother       Date:  2016-11-04       Impact factor: 3.747

6.  CAPA Analysis of Haemolysed Red Cell Unit Detected During Component Preparation: Importance of Quality Check on Cold Chain Maintenance.

Authors:  Babita Raghuwanshi; N K Pehlajani
Journal:  J Clin Diagn Res       Date:  2016-11-01

7.  Red blood cells ageing markers: a multi-parametric analysis.

Authors:  Manon Bardyn; Benjamin Rappaz; Keyvan Jaferzadeh; David Crettaz; Jean-Daniel Tissot; Inkyu Moon; Gerardo Turcatti; Niels Lion; Michel Prudent
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

Review 8.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

9.  Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity.

Authors:  Ruqayyah J Almizraq; Philip J Norris; Heather Inglis; Somaang Menocha; Mathijs R Wirtz; Nicole Juffermans; Suchitra Pandey; Philip C Spinella; Jason P Acker; Jennifer A Muszynski
Journal:  Blood Adv       Date:  2018-09-25

10.  Advancements in laboratory diagnostics: an invaluable tool for assessing quality of blood transfusions.

Authors:  Giuseppe Lippi; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-12-05       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.